(Q34029999)
Statements
1 reference
A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer (English)
1 reference
Alberto J Montero
1 reference
Kiran Avancha
1 reference
Stefan Glück
1 reference
Gilberto Lopes
1 reference
27 December 2011
1 reference
1 reference
132
1 reference
747-751
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference